Icahn School Of Medicine At Mount Sinai
Clinical trials sponsored by Icahn School Of Medicine At Mount Sinai, explained in plain language.
-
New program aims to break the cycle of reoffending for prisoners with brain injuries
Disease control OngoingThis study is testing whether a special support program can help people with brain injuries who are leaving prison. The program provides case management to connect them with medical care, job training, and housing. Researchers want to see if this support reduces the chance they r…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Ancient herbal formula tested for modern Crohn's disease
Disease control OngoingThis early-stage study is testing the safety and tolerability of an oral herbal formula called E-B-FAHF-2 in adults with mild-to-moderate Crohn's disease. The goal is to see if this concentrated plant-based medicine can safely help maintain remission, filling a gap where few appr…
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early trial aims to tame tough blood cancer with novel drug mix
Disease control OngoingThis early-phase study is testing a new three-drug combination (iberdomide, elotuzumab, and dexamethasone) for adults with multiple myeloma that has come back or stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see ho…
Phase: EARLY_PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Doctors test alcohol injection to starve prostate cancer
Disease control OngoingThis early-stage study is testing a new injection for men with high-risk prostate cancer. The injection uses alcohol and numbing medicine to block the nerves that feed the prostate, aiming to slow or stop the cancer's growth. Researchers will give the injection during a standard …
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Brain scans test if common drug can erase cocaine cravings
Disease control OngoingThis early-stage study is exploring whether the medication methylphenidate (Ritalin) can help weaken the powerful memories and cravings triggered by drug cues in people with cocaine addiction. Researchers will give 51 participants either the medication or a placebo and use brain …
Phase: EARLY_PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Revolutionary 3D eye scan could spot blindness risk earlier
Diagnosis OngoingThis study is testing a new, advanced eye scanner that takes extremely detailed 3D pictures of the retina. The goal is to see if this technology can help doctors detect and understand age-related macular degeneration (AMD) earlier and better. The study will involve 50 people, som…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 18, 2026 14:40 UTC
-
Faster scan could catch more liver cancer early
Diagnosis ENROLLING_BY_INVITATIONThis study is testing if a shorter, more affordable MRI scan is better than the standard ultrasound for finding early liver cancer in people with cirrhosis. Researchers will enroll 820 adults with cirrhosis who are already in a screening program. They will compare how well the fa…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 05, 2026 14:00 UTC
-
Texts and websites aim to boost Life-Saving cancer checks
Prevention ENROLLING_BY_INVITATIONThis study is testing a digital toolkit, including a website and text messages, to help more people complete their recommended colon cancer screening. It will involve 400 patients from community health centers who are due for screening. Researchers will compare the new digital su…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC
-
VR meditation could calm nerves and improve voice therapy
Symptom relief ENROLLING_BY_INVITATIONThis study is exploring whether starting voice therapy sessions with a guided meditation in virtual reality helps people learn and retain treatment better. It involves 60 participants with voice disorders and anxiety who will use a VR headset for meditation before their regular t…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Virtual escape pod tested to soothe ICU trauma
Symptom relief OngoingThis study is testing a special room called MIRA that uses calming sounds and visuals to help patients in the brain intensive care unit (ICU). The goal is to see if this relaxing experience is safe, practical, and can help reduce patients' pain, anxiety, and sleep problems. Resea…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 17, 2026 13:08 UTC
-
New program matches home care to Patient's changing needs
Symptom relief ENROLLING_BY_INVITATIONThis study is testing a new way to deliver palliative care at home for people with advanced heart failure or certain cancers. The care team grows as a patient's symptoms get worse, adding more specialists like nurses or doctors when needed. The goal is to see if this flexible app…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 16, 2026 15:27 UTC
-
Listening to patients to build better cancer care
Knowledge-focused OngoingThis study aims to understand the challenges and unmet needs of people living with advanced bladder cancer. Researchers will ask 210 patients to share their experiences through surveys and focus groups. The goal is to use this information to create better support tools and improv…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Can a new diabetes pill prevent dangerous blood clots?
Knowledge-focused OngoingThis study aims to understand if a newer diabetes drug (sotagliflozin) is better at reducing blood clot risk than an older one (empagliflozin). Researchers are testing 17 healthy volunteers, giving them both drugs at different times to compare their effects. They will measure how…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Major asthma study maps how 1,000+ patients respond to treatments
Knowledge-focused OngoingThis study aims to better understand the different types of asthma by observing over 1,000 people who already have it. Researchers are not testing a new treatment; instead, they are collecting real-world information on how patients with different asthma profiles respond to their …
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC
-
Tracking the real impact of cancer treatment on seniors
Knowledge-focused OngoingThis study aims to better understand how radiation therapy affects older adults with cancer. Researchers are following 150 patients aged 65 and older to track their ability to complete treatment, changes in daily function, and side effects. By collecting survey and assessment dat…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Can a 'Trust Hormone' nasal spray fix broken relationships?
Knowledge-focused TerminatedThis small, suspended pilot study aimed to see if a nasal spray containing oxytocin (a hormone linked to social bonding) could help people with borderline personality disorder (BPD) cooperate better with others. Researchers compared 40 adults with and without BPD playing a trust-…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC